These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3283031)

  • 1. [Monitoring of sterilization procedures for plasma derivatives using bacteriophages].
    Dichtelmüller H; Stephan W
    Immun Infekt; 1988 Feb; 16(1):18-20. PubMed ID: 3283031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of hepatitis viruses and HIV in plasma and plasma derivatives by treatment with beta-propiolactone/UV irradiation.
    Stephan W
    Curr Stud Hematol Blood Transfus; 1989; (56):122-7. PubMed ID: 2642784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Virus safety of labile plasma products from the German viewpoint].
    Stephan W
    Beitr Infusionsther; 1989; 24():40-5. PubMed ID: 2481547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biotest position on HIV-1 seroconversions in 1990 in 11 patients, treated with beta-propiolactone/uv virus inactivated PPSB].
    Pustoslemsek P; Kloft M; Kotitschke R
    Infusionsther Transfusionsmed; 1993 Dec; 20(6):344-6. PubMed ID: 8142739
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined use of ultraviolet irradiation and beta propiolactone sterilization of sera infected with a virus.
    SMOLENS J; STOKES J
    Proc Soc Exp Biol Med; 1954 Jul; 86(3):538-9. PubMed ID: 13194713
    [No Abstract]   [Full Text] [Related]  

  • 6. Virus safety of beta-propiolactone treated plasma preparations. Clinical experiences.
    Heinrich D; Sugg U; Brackmann HH; Stephan W; Lissner R
    Dev Biol Stand; 1987; 67():311-7. PubMed ID: 3649316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of HIV in plasma derivatives by beta-propiolactone and UV irradiation.
    Dichtelmüller H; Stephan W; Prince AM; Gürtler L; Deinhardt F
    Infection; 1987; 15(5):367-9. PubMed ID: 3121517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VIII concentrate from cold sterilized human plasma.
    Stephan W; Prince AM; Kotitschke R
    Dev Biol Stand; 1983; 54():491-5. PubMed ID: 6418593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus safe plasma exchange medium containing essential human plasma proteins.
    Kotitschke R; Stephan W; Lissner R; Heinrich D
    Prog Clin Biol Res; 1990; 337():399-401. PubMed ID: 2353002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combined treatment of serum containing hepatitis B virus with beta-propiolactone and ultraviolet irradiation.
    Stephan W; Berthold H; Prince AM
    Vox Sang; 1981 Sep; 41(3):134-8. PubMed ID: 7331286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PROPIOLACTONE PLUS ULTRAVIOLET-TREATED PLASMA WITHOUT HEPATITIS. SIX YEARS' EXPERIENCE.
    LOGRIPPO GA; WOLFRAM BR; BRUSH BE
    Arch Surg; 1964 Apr; 88():721-4. PubMed ID: 14107028
    [No Abstract]   [Full Text] [Related]  

  • 12. Inactivation of the Hutchinson strain of non-A, non-B hepatitis virus by combined use of beta-propiolactone and ultraviolet irradiation.
    Prince AM; Stephan W; Dichtelmüller H; Brotman B; Huima T
    J Med Virol; 1985 Jun; 16(2):119-25. PubMed ID: 3925077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta-propiolactone as a sterilizing agent in the manufacture of intravenous immunoglobulin preparations].
    Stephan W; Dichtelmüller H
    Arzneimittelforschung; 1983; 33(9):1230-1. PubMed ID: 6416260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The reaction of beta-propiolactone with serum proteins and amino acid derivatives (author's transl)].
    Determann H; Joachim HU
    Z Klin Chem Klin Biochem; 1971 Sep; 9(5):398-401. PubMed ID: 5173516
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inactivation of bacteria and coliphages in surface water highly polluted by secondary effluent and purified by flocculation and filtration by means of UV irradiation at a pilot plant scale].
    Dizer H; Bartocha W; Seidel K; López Pila JM; Grohmann A
    Zentralbl Hyg Umweltmed; 1993 Sep; 194(5-6):490-507. PubMed ID: 8267835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BETA-PROPIOLACTONE PLUS ULTRAVIOLET IRRADIATED PLASMA. A CLINICAL EVALUATION FOR HEPATITIS, TOXICITY AND ALLERGY.
    WOLFRAM BR; LOGRIPPO GA
    Bibl Haematol; 1964; 19():644-7. PubMed ID: 14267084
    [No Abstract]   [Full Text] [Related]  

  • 17. [Principles of selective inactivation of the viral genome. III. Kinetics of the inactivation of bacteriophage MS2 infectivity by beta-propiolactone].
    Budovskiĭ EI; Zalesskaia MA
    Mol Biol (Mosk); 1985; 19(4):1139-47. PubMed ID: 4047036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insufficient inactivation of HIV-1 in human cryo poor plasma by beta-propiolactone: results from a highly accurate virus detection method.
    Norley SG; Löwer J; Kurth R
    Biologicals; 1993 Sep; 21(3):251-8. PubMed ID: 8117438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Virus inactivation in plasma fractions for therapeutic use].
    Burnouf T; Martinache L; Goudemand M
    Nouv Rev Fr Hematol (1978); 1987; 29(1):93-6. PubMed ID: 3588282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of hepatitis B and non-A, non-B viruses by combined use of Tween 80, beta-propiolactone, and ultraviolet irradiation.
    Prince AM; Stephan W; Kotitschke R; Brotman B
    Thromb Haemost; 1983 Aug; 50(2):534-6. PubMed ID: 6415846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.